StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic fDA Premarket Approvals (PMA & Supplements) — Medtronic

U.S. FDA openFDA Device PMA Endpoint (Mapped to Medtronic April FY)

QuarterlyAnnualMonthly
Latest, FY2026
543
Period ended Apr 30, 2026
Change on a year earlier
+8.0%
503 in FY2025
History
13 years
Since FY2014
Sources
1
U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFDA Premarket Approvals (PMA & Supplements) — MedtronicYear on yearSource
FY2026Apr 30, 2026543+8.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2025Apr 30, 2025503-7.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2024Apr 30, 2024542+15.8%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2023Apr 30, 2023468-20.8%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2022Apr 30, 2022591-9.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2021Apr 30, 2021651-0.8%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2020Apr 30, 2020656+1.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2019Apr 30, 2019647-12.8%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2018Apr 30, 2018742+5.7%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2017Apr 30, 2017702+12.3%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2016Apr 30, 2016625-13.3%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2015Apr 30, 2015721+173.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
FY2014Apr 30, 2014264–U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗

Breakdown

What makes up fda premarket approvals (pma & supplements) — medtronic

Cite this data

StockData. (2026). Medtronic FDA Premarket Approvals (PMA & Supplements) — Medtronic, annual FY2014–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ext-fda-pma-co

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.